Skip to content
TREOCAPA

TREOCAPA

  • Home
  • About TREOCAPA
    • Aim of the study
    • Phase II
      • Study procedure
    • Phase III
      • Allocation of the participants in the study group
      • Study procedure
    • Potential risks & benefits
    • Participating centers
  • For public & patients
    • EFCNI: European Foundation for the Care of Newborn Infants
    • Patient information sheet – Phase II
    • Patient information sheet – Phase III
    • Factsheet designed by EFCNI
    • Q&A
  • For Investigators
  • Funding & sponsorship
  • News
  • TREOCAPA-LT
    • Funding, sponsorship and coordination
    • Patient information sheet
    • Download the questionnaire
    • Potential risks and benefits
  • Publications & outputs
    • 2023

Newsletters

Published May 3, 2022By Mélanie Durox
Categorized as Uncategorized

Post navigation

Previous post

Funding & sponsorship

Next post

News

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777389.

The Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

  • For public & patients
TREOCAPA
Proudly powered by WordPress.